G. Michael Allan, Hoan Linh Banh, Jonathan D. Ference
Abstract
When stopping oral anticoagulants (like warfarin) after treatment of venous thromboembolism (VTE), should acetylsalicylic acid (ASA) be offered? Once warfarin treatment for unprovoked VTE is complete, low-dose ASA prevents recurrent VTE for 1 in 19 patients over 2.5 years with no increase in major
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
When stopping oral anticoagulants (like warfarin) after treatment of venous thromboembolism (VTE), should acetylsalicylic acid (ASA) be offered? Once warfarin treatment for unprovoked VTE is complete, low-dose ASA prevents recurrent VTE for 1 in 19 patients over 2.5 years with no increase in major
Key concepts: Warfarin, Medicine, Venous thromboembolism, Intensive care medicine, Internal medicine, Thrombosis, Atrial fibrillation